ASH-ASTCT-NMDP Letter to MAC Medical Directors on National Coverage Decision on HSCT for MDS
Citations
American Society of Hematology. (2024).
ASH-ASTCT-NMDP Letter to MAC Medical Directors on National Coverage Decision on HSCT for MDS.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-astct-nmdp-letter-to-mac-medical-directors-on-national-coverage-decision-on-hsct-for-mds.
American Society of Hematology.
"ASH-ASTCT-NMDP Letter to MAC Medical Directors on National Coverage Decision on HSCT for MDS." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-astct-nmdp-letter-to-mac-medical-directors-on-national-coverage-decision-on-hsct-for-mds
(label-accessed February 12, 2025).
"American Society of Hematology."
ASH-ASTCT-NMDP Letter to MAC Medical Directors on National Coverage Decision on HSCT for MDS, 12 Feb. 2025 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-astct-nmdp-letter-to-mac-medical-directors-on-national-coverage-decision-on-hsct-for-mds.